RNASEL 21385G/A polymorphism and cancer risk: A meta-analysis based on 21 case-control studies

Molecular Biology Reports

Volumn 38, Issue 8, 2011, Pages 5099-5105

  Zhang, Li Feng ^a   Mi, Yuan Yuan ^a   Qin, Chao ^a   Wang, Yong ^a   Cao, Qiang ^a   Wei, Jun Feng ^a   Zhou, Yao Jun ^a   Feng, Ning Han ^a   Zhang, Wei ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Cancer risk; Meta analysis; Polymorphism; RNASEL

Indexed keywords

ALANINE; GLYCINE; 2 5A DEPENDENT RIBONUCLEASE; 2-5A-DEPENDENT RIBONUCLEASE; RIBONUCLEASE;

ACCURACY; ARTICLE; BREAST CANCER; CANCER PATIENT; CANCER RISK; CASE CONTROL STUDY; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; ENDORIBONUCLEASE L GENE; ETHNICITY; GENE FREQUENCY; GENE FUNCTION; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS (TOPIC); MOLECULAR PATHOLOGY; PANCREAS CANCER; PROSTATE CANCER; RACE DIFFERENCE; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW; TUMOR SUPPRESSOR GENE; ENZYMOLOGY; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; NEOPLASM; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM;

CASE-CONTROL STUDIES; ENDORIBONUCLEASES; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 84855227023     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0657-2     Document Type: Article

References (36)

1. Pogo BG, Holland JF (1997) Possibilities of a viral etiology for human breast cancer-a review. Biol Trace Elem Res 56:131-142 (Pubitemid 27198256)
2. Laghi L, Randolph AE, Chauhan DP, Marra G, Major EO, Neel JV, Boland CR (1999) JC virus DNA is present in the mucosa of the human colon and in colorectal cancers. Proc Natl Acad Sci USA 96:7484-7489 (Pubitemid 29299688)
3. Silverman RH (2003) Implications for RNase L in prostate cancer biology. Biochemistry 42:1805-1812 (Pubitemid 36258654)
4. Hassel BA, Zhou A, Sotomayor C, Maran A, Silverman RH (1993) A dominant negative mutant of 2-5A-dependent RNase suppresses antiproliferative and antiviral effects of interferon. EMBO J 12:3297-3304 (Pubitemid 23232761)
5. Lengyel P (1993) Tumour-suppressor genes: news about the interferon connection. Proc Natl Acad Sci USA 90:5893-5895 (Pubitemid 23191419)
6. Carpten J, Nupponen N, Isaacs S, Sood R, Robbins C, Xu J, Faruque M, Moses T, Ewing C, Gillanders E, Hu P, Bujnovszky P, Makalowska I, Baffoe-Bonnie A, Faith D, Smith J, Stephan D, Wiley K, Brownstein M, Gildea D, Kelly B, Jenkins R, Hostetter G, Matikainen M, Schleutker J, Klinger K, Connors T, Xiang Y
7. Wang Z, De Marzo A, Papadopoulos N, Kallioniemi OP, Burk R, Meyers D, Grönberg H, Meltzer P, Silverman R, Bailey-Wilson J, Walsh P, Isaacs W, Trent J (2002) Germline mutations in the ribonuclease L gene in families showing linkage with HPC1. Nat Genet 30:181-184
8. Wagenlehner FM, Elkahwaji JE, Algaba F, Bjerklund-Johansen T, Naber KG, Hartung R, Weidner W (2007) The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int 100:733-737 (Pubitemid 47360188)
9. Zhou A, Paranjape J, Brown TL, Nie H, Naik S, Dong B, Chang A, Trapp B, Fairchild R, Colmenares C, Silverman RH (1997) Interferon action and apoptosis are defective in mice devoid of 2', 5'-oligoadenylate-dependent RNase L. EMBO J 16:6355-6363 (Pubitemid 27483262)
10. Zhou A, Hassel BA, Silverman RH (1993) Expression cloning of 2-5A-dependent RNAase: a uniquely regulated mediator of interferon action. Cell 72:753-765 (Pubitemid 23093883)
11. XiangY,WangZ, Murakami J, Plummer S,Klein EA, Carpten JD, Trent JM, Isaacs WB, Casey G, Silverman RH (2003) Effects of RNase L mutations associated with prostate cancer on apoptosis induced by 2', 5'-oligoadenylates. Cancer Res 63:6795-6801 (Pubitemid 37322961)
12. Casey G, Neville PJ, Plummer SJ, Xiang Y, Krumroy LM, Klein EA, Catalona WJ, Nupponen N, Carpten JD, Trent JM, Silverman RH, Witte JS (2002) RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases. Nat Genet 32:581-583 (Pubitemid 35435169)
13. Cybulski C, Wokołorczyk D, Jakubowska A, Gliniewicz B, Si-korski A, Huzarski T, Debniak T, Narod SA, Lubiński J (2007) DNA variation in MSR1, RNASEL and E-Cadherin genes and prostate cancer in Poland. Urol Int 79:44-49 (Pubitemid 47051818)
14. Daugherty SE, Hayes RB, Yeager M, Andriole GL, Chatterjee N, Huang WY, Isaacs WB, Platz EA (2007) RNASEL Arg462Gln polymorphism and prostate cancer in PLCO. Prostate 67:849-854 (Pubitemid 46828938)
15. Krüger S, Engel C, Bier A, Silber AS, Görgens H, Mangold E, Pagenstecher C, Holinski-Feder E, von Knebel Doeberitz M, Royer-Pokora B, Dechant S, Pox C, Rahner N, Müller A, Schackert HK, German HNPCC Consortium (2007) The additive effect of p53 Arg72Pro and RNASEL Arg462Gln genotypes on age of disease onset in Lynch syndrome patients with pathogenic germline mutations in MSH2 or MLH1. Cancer Lett 252:55-64 (Pubitemid 46734555)
16. Nam RK, Zhang WW, Jewett MA, Trachtenberg J, Klotz LH, Emami M, Sugar L, Sweet J, Toi A, Narod SA (2005) The use of genetic markers to determine risk for prostate cancer at prostate biopsy. Clin Cancer Res 11:8391-8397 (Pubitemid 41746952)
17. Krüger S, Silber AS, Engel C, Görgens H, Mangold E, Pagen-stecher C, Holinski-Feder E, von Knebel Doeberitz M, Moeslein G, Dietmaier W, Stemmler S, Friedl W, Rüschoff J, Schackert HK, German Hereditary Non-Polyposis Colorectal Cancer Consortium (2005) Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study. Lancet Oncol 6:566-572 (Pubitemid 41051934)
18. Bartsch DK, Fendrich V, Slater EP, Sina-Frey M, Rieder H, Greenhalf W, Chaloupka B, Hahn SA, Neoptolemos JP, Kress R (2005) RNASEL germline variants are associated with pancreatic cancer. Int J Cancer 117:718-722 (Pubitemid 41598821)
19. Beuten J, Gelfond JA, Franke JL, Shook S, Johnson-Pais TL, Thompson IM, Leach RJ (2010) Single and multivariate associations of MSR1, ELAC2, and RNASEL with prostate cancer in an ethnic diverse cohort of men. Cancer Epidemiol Biomarkers Prev 19:588-599
20. Tsilidis KK, Helzlsouer KJ, Smith MW, Grinberg V, Hoffman-Bolton J, Clipp SL, Visvanathan K, Platz EA (2009) Association of common polymorphisms in IL10, and in other genes related to inflammatory response and obesity with colorectal cancer. Cancer Causes Control 20:1739-1751
21. Robbins CM, Hernandez W, Ahaghotu C, Bennett J, Hoke G, Mason T, Pettaway CA, Vijayakumar S, Weinrich S, Furbert-Harris P, Dunston G, Powell IJ, Carpten JD, Kittles RA (2008) Association of HPC2/ELAC2 and RNASEL non-synonymous variants with prostate cancer risk in African American familial and sporadic cases. Prostate 68:1790-1797
22. Wiklund F, Jonsson BA, Brookes AJ, Strömqvist L, Adolfsson J, Emanuelsson M, Adami HO, Augustsson-Bälter K, Grönberg H (2004) Genetic analysis of the RNASEL gene in hereditary, familial, and sporadic prostate cancer. Clin Cancer Res 10: 7150-7156 (Pubitemid 39487699)
23. Nakazato H, Suzuki K, Matsui H, Ohtake N, Nakata S, Yama-naka H (2003) Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population. Br J Cancer 89:691-696 (Pubitemid 37076175)
24. Rökman A, Ikonen T, Seppälä EH, Nupponen N, Autio V, Mo-nonen N, Bailey-Wilson J, Trent J, Carpten J, Matikainen MP, Koivisto PA, Tammela TL, Kallioniemi OP, Schleutker J (2002) Germline alterations of the RNASEL gene, a candidate HPC1 gene at 1q25, in patients and families with prostate cancer. Am J Hum Genet 70:1299-1304 (Pubitemid 34450579)
25. Sevinç A, Yannoukakos D, Konstantopoulou I, Manguoglu E, Lüleci G, Colak T, Akyerli C, Colakoglu G, Tez M, Sayek I, Gerassimos V, Nasioulas G, Papadopoulou E, Florentin L, Kontogianni E, Bozkurt B, Kocabas NA, Karakaya AE, Yulug IG, Ozçelik T (2004) Lack of association between RNASEL Arg462Gln variant and the risk of breast cancer. Anticancer Res 24:2547-2549 (Pubitemid 39166345)
26. Maier C, Haeusler J, Herkommer K, Vesovic Z, Hoegel J, Vogel W, Paiss T (2005) Mutation screening and association study of RNASEL as a prostate cancer susceptibility gene. Br J Cancer 92:1159-1164 (Pubitemid 40546684)
27. Wang L, McDonnell SK, Elkins DA, Slager SL, Christensen E, Marks AF, Cunningham JM, Peterson BJ, Jacobsen SJ, Cerhan JR, Blute ML, Schaid DJ, Thibodeau SN (2002) Analysis of the RNASEL gene in familial and sporadic prostate cancer. Am J Hum Genet 71:116-123 (Pubitemid 34734712)
28. Shea PR, Ishwad CS, Bunker CH, Patrick AL, Kuller LH, Ferrell RE (2008) RNASEL and RNASEL-inhibitor variation and prostate cancer risk in Afro-Caribbeans. Prostate 68:354-359 (Pubitemid 351342641)
29. Shook SJ, Beuten J, Torkko KC, Johnson-Pais TL, Troyer DA, Thompson IM, Leach RJ (2007) Association of RNASEL variants with prostate cancer risk in Hispanic Caucasians and African Americans. Clin Cancer Res 13:5959-5964 (Pubitemid 47583924)
30. DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177-188 (Pubitemid 17189972)
31. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
32. Summers K, Crespi B (2008) Molecular evolution of the prostate cancer susceptibility locus RNASEL: evidence for positive selection. Infect Genet Evol 8:297-301
33. Bisbal C, Silverman RH (2007) Diverse functions of RNase L and implications in pathology. Biochimie 89:789-798 (Pubitemid 47008946)
34. Ioannidis JP (1998) Effect of the statistical significance of results on the time to completion and publication of randomized efficacy trials. JAMA 279:281-286
35. Pharoah PD, Dunning AM, Ponder BA, Easton DF (2004) Association studies for finding cancer-susceptibility genetic variants. Nat Rev Cancer 4:850-860 (Pubitemid 39472952)
36. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, Spitz MR (2000) Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst 92:1764-1772